For research use only. Not for therapeutic Use.
Apitegromab（Cat No.:I042173）is an investigational monoclonal antibody that targets and inhibits the protein myostatin, a negative regulator of muscle growth. Myostatin plays a key role in limiting muscle development and repair, and by blocking it, apitegromab aims to promote muscle growth and improve muscle function. This drug is being studied for its potential to treat neuromuscular disorders like spinal muscular atrophy (SMA), a condition characterized by muscle weakness and atrophy. Clinical trials are evaluating its safety, efficacy, and ability to enhance muscle strength, function, and overall patient outcomes in affected individuals.
| Catalog Number | I042173 |
| CAS Number | 2278276-46-1 |
| Purity | ≥95% |
